Deborah Cosentini Selected Research

Deborah Cosentini Research Topics

Disease

26	Adrenocortical Carcinoma 02/2024 - 12/2018
22	Neoplasms (Cancer) 11/2023 - 11/2018
12	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2021
5	Disease Progression 11/2023 - 12/2019
3	Asthenia 02/2024 - 01/2022
3	Hypertension (High Blood Pressure) 02/2024 - 01/2021
3	Neoplasm Metastasis (Metastasis) 04/2023 - 11/2018
3	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2021 - 12/2018
2	Vomiting 04/2024 - 01/2022
2	Nausea 04/2024 - 01/2022
2	Pain (Aches) 02/2024 - 01/2022
2	Body Weight (Weight, Body) 12/2023 - 07/2022
2	Weight Gain 12/2023 - 09/2023
2	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 12/2022
1	Diarrhea 04/2024
1	Respiratory Insufficiency (Respiratory Failure) 02/2024
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2024
1	Paraganglioma (Paragangliomas) 02/2024
1	Hemorrhage 02/2024
1	Bone Fractures (Bone Fracture) 01/2024
1	Overweight 12/2023
1	Weight Loss (Weight Reduction) 12/2023
1	Bone Resorption 10/2023
1	Uterine Hemorrhage (Uterine Bleeding) 09/2023
1	Hyperglycemia 09/2023
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2023
1	Restless Legs Syndrome (Restless Legs) 12/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2022
1	Dysgeusia (Parageusia) 08/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022
1	Constipation 01/2022
1	Cushing Syndrome 01/2022
1	Neutropenia 01/2022
1	Alopecia (Baldness) 06/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Lymphatic Metastasis 01/2021
1	COVID-19 01/2021
1	Anemia 01/2021
1	Flushing 03/2019

Drug/Important Bio-Agent (IBA)

14	Mitotane (Lysodren)FDA Link 10/2023 - 11/2018
4	Aromatase InhibitorsIBA 01/2024 - 11/2022
4	Hormones (Hormone)IBA 10/2023 - 11/2018
4	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023 - 04/2020
4	Etoposide (VP 16)FDA LinkGeneric 09/2023 - 04/2020
4	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 04/2020
4	Progesterone FDA LinkGeneric 04/2023 - 01/2019
3	AndrogensIBA 01/2023 - 01/2019
3	TrabectedinIBA 01/2023 - 08/2018
2	sacituzumab govitecanIBA 04/2024 - 01/2023
2	Denosumab FDA Link 01/2024 - 11/2022
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 12/2022
2	Testosterone (Sustanon)FDA Link 01/2023 - 12/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 11/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 12/2019
1	Ado-Trastuzumab EmtansineIBA 04/2024
1	Nicorandil (SG 75)IBA 04/2024
1	Immunoconjugates (Immunoconjugate)IBA 04/2024
1	trastuzumab deruxtecanIBA 04/2024
1	Sunitinib (Sutent)FDA Link 02/2024
1	selpercatinibIBA 11/2023
1	MineralsIBA 10/2023
1	Progestins (Progestagens)IBA 09/2023
1	Megestrol Acetate (Borea)FDA LinkGeneric 09/2023
1	Diphosphonates (Bisphosphonates)IBA 11/2022
1	OsilodrostatIBA 01/2022
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2022
1	Metyrapone FDA Link 01/2022
1	Peptide YYIBA 01/2022
1	ribociclibIBA 01/2022
1	Gemcitabine FDA Link 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Alkylating AgentsIBA 04/2020
1	LutetiumIBA 01/2020
1	Radioisotopes (Radionuclides)IBA 01/2020
1	GalliumIBA 01/2020
1	YttriumIBA 01/2020
1	AcidsIBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	Edotreotide (SMT 487)IBA 01/2020
1	somatostatin receptor 2IBA 01/2020
1	cabazitaxel FDA Link 12/2019
1	artemisinin (artemisinine)IBA 11/2019

Therapy/Procedure

19	Therapeutics 02/2024 - 01/2019
11	Drug Therapy (Chemotherapy) 12/2023 - 12/2019
5	Immunotherapy 11/2023 - 12/2018
5	Adjuvant Chemotherapy 01/2023 - 01/2021
1	Cryosurgery 02/2024
1	Mediterranean Diet 12/2023
1	Radiotherapy 01/2023
1	Castration 12/2022
1	Cytoreduction Surgical Procedures 01/2022